Alonso Moreno F J, García Palencia M, Laborda Peralta M, Hermoso López A, Lopez de Castro F
Centros de Salud de Yepes y Ocaña, Toledo.
Aten Primaria. 1998 May 31;21(9):607-12.
The target of this study is to analyse the cost and the relation cost-effectiveness of different antihypertensive drug therapies.
A descriptive study have been followed in a single sample of 216 patients over 14 years old with high blood pressure. They have been studied between 1/7/1995 and 30/6/1996.
An rural Health Centres.
The cost of the antihypertensive drug therapies were calculated depending of the dosage prescribed and the prizes of 1996. The relation cost-effectiveness was calculated by multiplying the average cost monthly of the drugs therapies by the total number of patients and dividing by patients controlled the average of the last three tests blood pressure < 140/90). The average prize monthly of the drug therapies was 2574 pts for patient, with a std dev of 1965.
The ACE inhibitors and the calcium channel blockers show higher relation cost-effectiveness than the diuretics. Meanwhile the election of antihypertensive drugs therapies must be essentials clinic criterion. We think that the cost of antihypertensives therapies, the effectiveness and the relation cost-effectiveness should be considered by the general practitioners.
本研究旨在分析不同抗高血压药物治疗的成本及其成本效益关系。
对216例14岁以上高血压患者的单一样本进行了为期14年的描述性研究。研究时间为1995年7月1日至1996年6月30日。
一家农村健康中心。
根据1996年规定的剂量和价格计算抗高血压药物治疗的成本。成本效益关系的计算方法是，将药物治疗的月平均成本乘以患者总数，再除以血压得到控制（最近三次血压测试平均值<140/90）的患者人数。药物治疗的月平均费用为每位患者2574比塞塔，标准差为1965。
与利尿剂相比，血管紧张素转换酶抑制剂和钙通道阻滞剂显示出更高的成本效益关系。同时，抗高血压药物治疗的选择必须基于基本的临床标准。我们认为，全科医生应考虑抗高血压治疗的成本、疗效及成本效益关系。
